Palisade Bio Inc. Stock
Palisade Bio Inc. Stock
We see a rather positive sentiment for Palisade Bio Inc. with 8 Buy predictions and 1 Sell predictions.
With a target price of 10 € there is potential for a 2830.83% increase which would mean more than doubling the current price of 0.34 € for Palisade Bio Inc..
Our community identified positive and negative aspects for Palisade Bio Inc. stock for the coming years. 1 users see the criterium "Company culture" as a plus for the Palisade Bio Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Palisade Bio Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Palisade Bio Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Palisade Bio Inc. | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | 0.680% | -5.195% | -17.700% | -28.711% | 7.908% | -63.057% | -91.198% |
| Pacira Pharmaceuticals | 0.970% | -0.962% | 1.980% | -7.207% | -4.630% | -48.756% | -60.762% |
| Savara Inc. | 3.070% | -15.207% | -8.341% | 49.029% | -21.830% | 158.938% | 154.172% |
Comments
Palisade Bio (PALI) is now covered by Wolfe Research. They set an "outperform" rating and a $7.00 price target on the stock.
Show more
Ratings data for PALI provided by MarketBeat
Palisade Bio (PALI) is now covered by HC Wainwright. They set a "buy" rating and a $7.00 price target on the stock.
Show more
Ratings data for PALI provided by MarketBeat
Palisade Bio (PALI) is now covered by Stifel Nicolaus. They set a "buy" rating and a $5.00 price target on the stock.
Show more
Ratings data for PALI provided by MarketBeat